Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.
Frequently asked questions
What sector does Sirio Pharma (300791) operate in?
Sirio Pharma belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is Sirio Pharma (300791) current stock price?
As of the latest data, Sirio Pharma stock price is CN¥17.13, with a previous close of CN¥17.13.
What is Sirio Pharma (300791) current market capitalization?
Sirio Pharma market cap is approximately 5.29 billion.
What is Sirio Pharma (300791) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.39, and the forward EPS is CN¥1.56.
What is Sirio Pharma (300791) Price-to-Earnings (P/E) ratio?
Sirio Pharma current P/E ratio is 43.92, with a forward P/E of 10.98.
Does Sirio Pharma (300791) pay dividends?
Yes. Sirio Pharma pays annual dividends with an annualized yield of 0.76% and an estimated annual payout of CN¥0.13 per share.
When is the next ex-dividend date for Sirio Pharma (300791)?
The next ex-dividend date is scheduled for June 05, 2027.
What is Sirio Pharma (300791) beta (volatility) score?
Sirio Pharma has a beta of 0.242, indicating lower volatility than the overall market.